Abstract:Background: Cathelicidin LL-37 is the human member of a family of antimicrobial peptides that are released from activated neutrophils and monocytes at sites of acute inflammation.Recently it has been shown that LL-37 is a promising new biomarker for active antibodyassociated vasculitis both for prognosis and therapy guidance.We determined the association between circulating LL-37 levels and IBD disease activity, including strictures.Methods: Serum samples were collected from an institutional IBD biobank and separated into two cohorts.Cohort 1 was composed of 57 UC patients and 67 CD patients.Cohort 2 was composed of 21 UC patients and 28 CD patients.Cathelicidin serum levels were measured by ELISA.As our data indicated that LL-37 levels are inversely correlated to clinical IBD disease activity, the cohorts were divided into tertiles based on high, middle, and low cathelicidin levels.UC and CD clinical disease activity were quantified using Partial Mayo Score (PMS) and Harvey Bradshaw Index (HBI) respectively.Results: The age at blood sample collection, medication, CRP levels, and gender ratio of both cohorts are similar.In UC groups, cohort 1 has a longer duration of disease and higher PMS than cohort 2. In CD groups, cohort 2 has a lower HBI and more stricture patients than cohort 1.In UC patients, serum LL-37 levels in the low and middle tertiles (below 54 ng/mL) and CRP levels in the higher tertile (>2 mg/L) reflected moderate and severe clinical disease activity (PMS of 5 or above) with similar accuracy.The area under the curve (AUC) of the receiver operating characteristic (ROC) curves for both CRP and LL-37 were around 0.7, suggesting moderate accuracy.Alternatively, serum LL-37 levels in the high tertile (>54 ng/mL) and CRP levels in the lower tertile (<0.5mg/L) reflected UC remission (PMS of 0-2) with moderate accuracy (AUC=0.65).LL-37 was as accurate as CRP in indicating UC disease activity.In attempting to optimize the accuracy of LL-37 as an IBD biomarker, we found that co-existing low LL-37 levels and high CRP levels indicated moderate and severe UC with a high accuracy (AUC=0.80)better than that of either test alone.On the other hand, a combination of high LL-37 and low CRP levels indicated UC remission with higher accuracy (AUC=0.81)than either test alone (AUC= 0.64-0.66).High serum LL-37 levels (AUC=0.71)were also as accurate as low CRP levels (AUC=0.68) in indicating CD remission, although pairing the tests did not show an increase in accuracy.Low LL-37 levels and the remission status (HBI of 5 or less) of CD patients strongly indicated the presence of strictures with high specificity (0.90).Conclusion: The combination of circulating LL-37 with CRP levels and LL-37 levels with remission status can serve as a highly accurate biomarker for indicating clinical IBD disease activities and presence of stricture.

Correlation between expression of human cathelicidin peptide LL-37 and colon inflammation in patients with ulcerative colitis

The expression of leptin in human ulcerative colitis and its role in pathogenesis

Colonic epithelial cathelicidin (LL-37) expression intensity is associated with progression of colorectal cancer and presence of CD8+ T cell infiltrate

Expression of Monocyte Chemoatractant Protein 1 in Colonic Mucosa of Patients with Ulcerative Colitis.

Mo1318 Direct Comparison of In Vivo Drug Release Profiles of Three Locally-Acting Drug Products of Mesalamine in the Gastrointestinal Tract and Correlation With Systemic Exposure and Fecal Concentrations in Healthy Humans

CD177+ Neutrophils and Its Correlation with Mucosal Impairment in Patients with Inflammatory Bowel Disease

The Expressions of IL-2, IL-4, IL-17 and IL-10 in Ulcerative Colitis (UC) Mucosa and Its Relation with Disease Activity

Correlation Of Hypoxia-Inducible Facto-1 Alpha And C-Reactive Protein With Disease Evaluation In Patients With Ulcerative Colitis

Clinical significance of expression of peroxisome proliferator-activated receptor γ coactivator 1α in the inflamed mucosa of patients with inflammatory bowel disease

IL-27 induces LL-37/CRAMP expression from intestinal epithelial cells: implications for immunotherapy of <i>Clostridioides difficile</i> infection

IL-27 induces LL-37/CRAMP expression from intestinal epithelial cells: implications for immunotherapy of Clostridioides difficile infection

Significance of interleukin-27 expression in the intestinal mucosa of patients with inflammatory bowel disease

Expressions of KIR2DL1 and KIR2DL3 in Peripheral Blood and Intestinal Tissue in Patients with Inflammatory Bowel Disease

Expression of integrin α4β7 and intestinal lymphocyte homing in rats with ulcerative colitis

Expression and Clinical Significance of IL-17 and IL-17 Receptor in Ulcerative Colitis.

The Possible Role of the Novel Cytokines Il-35 and Il-37 in Inflammatory Bowel Disease.

Role and significance of lymphotoxin α1/β2 and its receptor LTβR in intestinal mucosal immunity of ulcerative colitis

Expression and Implication of Toll-like Receptors TLR2, TLR4 and TLR9 in Colonic Mucosa of Patients with Ulcerative Colitis

Expressions and Significance of CXC Chemokine Receptor Type 2 and Interleukin-8 in Patients with Inflammatory Bowel Disease

The role of enhanced expression of Cx43 in patients with ulcerative colitis

The Expression of HBD-2, NF-kB, IL-6 and IL-23 in Colonic Mucosa of Ulcerative Colitis and Irritable Bowel Syndrome